With the enormous amount of data being collected and entered into EHRs, the human brain (in this case the physician brain) is probably tuning out information that would probably stay if there was a conversation with the patient instead.
Although Thomas Eric Duncan informed Texas Health Presbyterian Hospital in Dallas when he arrived with a fever and other symptoms that he had traveled to West Africa, he was sent home. But was an electronic health record (EHR) to blame for the fact that someone did not connect the dots between the patient and the Ebola virus?
After Mr Duncan was readmitted back to the hospital and he had tested positive for the virus, the hospital placed the blame for the botched diagnosis on a flaw on its EHR from Epic.
“Protocols were followed by both the physician and the nurses,” the hospital released in a statement. “However, we have identified a flaw in the way the physician and nursing portions of our electronic health records (EHR) interacted in this specific case.”
The hospital then pointed to the separate physician and nursing workflows, which meant the patient’s travel history—located in the nursing workflow portion—did not appear automatically in the physician’s workflow.
However, the hospital quickly backtracked the next day to clarify that “there was no flaw in the EHR in the way the physician and nursing portions interacted related to this event.”
This means that when the patient’s travel history to West Africa was documented, the information was available to the full care team.
However, the confusion surrounding the effectiveness of the hospital’s EHR raises the question of what other issues could be missed?
“Even scarier than that mistake, though, is the certainty that similar ones lie in wait for all of us who cope with medical information stored in digital piles grown so gigantic, unwieldy and unreadable that sometimes we wind up working with no information at all,” Abigail Zuger, MD, wrote in The New York Times.
With the enormous amount of data being collected and entered into EHRs, the human brain (in this case the physician brain) is probably tuning out information that would probably stay if there was a conversation with the patient instead, she contends.
Read Dr Zuger's full commentary on The New York Times: http://nyti.ms/1p8Rfht
NCCN Guidelines Update Adds Momelotinib Below Ruxolitinib for High-, Low-Risk Myelofibrosis
January 23rd 2024Momelotinib was given category 2A and 2B status for patients with high- and low-risk myelofibrosis (MF) and MF with anemia. However, ruxolitinib retains a higher category of recommendation as a treatment for patients with MF.
Read More
Oncology Onward: A Conversation With Dr Shereef Elnahal, Under Secretary for Health
April 20th 2023Shereef Elnahal, MD, MBA, under secretary for health at the Veterans Health Administration (VHA), sat for a conversation with our hosts Emeline Aviki, MD, MBA, Memorial Sloan Kettering Cancer Center, and Stephen Schleicher, MD, MBA, Tennessee Oncology, that covered the cancer footprint of the VHA.
Listen
Interventions Needed to Increase DMT Uptake in Sickle Cell Disease
December 26th 2023A recent study found that uptake of disease-modifying therapies (DMTs) has been low among patients with sickle cell disease, suggesting that more interventions that consider individual patient characteristics are needed to improve adoption.
Read More
Exploring Payer Coverage Decisions Following FDA Novel Drug Approvals
May 3rd 2022On this episode of Managed Care Cast, Ari D. Panzer, BS, lead author and researcher, then at Tufts Medical Center—now at Duke University—discusses the findings from his team’s investigation into coverage decisions by health plan insurers of the 66 drugs approved by the FDA in 2018.
Listen
Exagamglogene Autotemcel Meets End Points in Severe Sickle Cell Disease, β-Thalassemia
December 7th 2023Two posters set to be presented at the 65th American Society of Hematology Annual Meeting & Exposition met their primary and secondary end points regarding exagamglogene autotemcel therapy for sickle cell disease and β-thalassemia.
Read More